维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="Platzbecker"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Chelerythrin activates caspase-8,downregulates FLIP long and short,and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells显示文摘	Platzbecker U Ward JL Deeg HJ	2003	Br J Haematol2003，122，3：	1
2	Update on de,elop- ments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS) : consensus statements and report from an expert workshop 显示文摘	Platzbecker U Santini V Mufti GJ	2012	Leuk Res2012，36，3：	1
3	Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia显示文摘	Brigitte Mohr Johannes Schetelig Kerstin Sch?fer‐Eckart Norbert Schmitz Mathias H?nel Wolf R?sler Norbert Frickhofen Hartmut Link Andreas Neubauer Ulrich Schuler Uwe Platzbecker Jan M. Middeke Gerhard Ehninger Martin Bornh?user Markus Schaich Friedrich St	2013	Br J Haematol2013，，：	1
4	P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
5	Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation显示文摘	Schroeder T Czibere A Platzbecker U	2013	Leukemia2013，27，6：	1
6	Allogeneic trans, plantation of CD34^+ selected hematopoietic cells-clinical problems and current challenges 显示文摘	Platzbecker U Ehninger G Bomhauser M	2004	Leuk Lymphoma2004，45，3：	1
7	The clinical,quality of life,and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes显示文摘	Platzbecker U Hofbauer LC Ehninger G		0，，05：	1
8	Phase 2 study of oral panobinostat (LBH589) with or without eryth- ropoietin in heavily transfusion-dependent IPSS low or int- 1 MDS patients显示文摘	Platzbecker U A1-Ali H K Gattermann N	2014	Leukemia2014，28，3：	1
9	P-glycoprotein-rnediated dr- ug effiux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate 显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
10	Azacitidine for treatment of patients with myelodysplastic syndromes (MDS):practical recommendations of the German MDS Study Group显示文摘	G?tze K Platzbecker U Giagounidis A		0，，09：	1
11	Stem cell transplantation for patients with Evans syndrome显示文摘	Benesch M Urban C Platzbecker U et a1	2009	Expert Rev Clin Immunol2009，5，3：	1
12	P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
13	Who benefits from allogeneic transplantation for myelodysplastic syndromes: new insights 显示文摘	Platzbecker U	2013	Hematology Am Soc Hematol Educ Program2013，2013，：	1
14	Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneie HSCT:results of the RELAZA trial显示文摘	Platzbecker U Wermke M Radke J	2012	Leukemia2012，26，3：	1
15	Activity of sirolimus in patients with myelodysplastic syndrome: results of a pilot study 显示文摘	Platzbecker U Haase M Herbst R	2005	Br J Haematol2005，128，5：	1
16	Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial 显示文摘	Platzbecker U Wennke M Radke J	2012	Leukemia2012，26，3：	1
17	Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation 显示文摘	Schroeder T Czibere A Platzbecker U	2013	Leukemia2013，27，6：	1
18	Sequential combination of azacitidine and lenalidomide in del (5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia:a phase Ⅰ study显示文摘	Platzbecker U Braulke F Kündgen A	2013	Leukemia2013，27，6：	1
19	Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin 显示文摘	Platzbecker U Klinge K Thiedel C	2001	Bone Marrow Transplantation2001，27，1：	1
20	Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle显示文摘	Eckardt K Sell H Taube A Koenen M Platzbecker B Cramer A		0，，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示